Toward T J, Johnson F J, Boult J E, Maillard J-Y
Division of Pharmacology, Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cathays Park, Cardiff CF10 3XF, UK.
Int Immunopharmacol. 2005 Apr;5(4):771-82. doi: 10.1016/j.intimp.2004.12.006.
Guinea-pigs were inoculated with parainfluenza type 3 (PI3) virus (5.2 x 10(7)) or medium (125 microl each nostril). The PDE4-inhibitor, rolipram (1 mg kg(-1)), the corticosteroid, dexamethasone (20 mg kg(-1)), or vehicle were administered (i.p.) 24 h and 0.5 h before inoculation and for 4 days thereafter. Respiratory function, recorded in conscious guinea-pigs as specific airways conductance (sGaw) by whole-body plethysmography, was unaffected over 4 days by inoculation with medium or PI3. Inhaled histamine (nose-only, 1 mM, 20 s) 24 h before inoculation produced no response but 4 days after PI3 inoculation, a significant (P<0.001) bronchoconstriction occurred, indicating airway hyperreactivity (AHR). Dexamethasone or rolipram treatment inhibited the AHR. Four days after PI3- or medium-inoculation, animals underwent bronchoalveolar lavage (BAL) for total and differential (macrophages, eosinophils and neutrophils) cell counts and determination of nitric oxide (NO) as nitrite and nitrate. Compared with medium-inoculated animals, BAL fluid removed 4 days after PI3 inoculation had significantly increased macrophages, eosinophils and neutrophils. Dexamethasone or rolipram significantly (P<0.05) reduced the PI3-induced airways influx of macrophages (by 40% and 47%), eosinophils (79% and 84%) and neutrophils (58% and 61%). PI3-inoculation significantly (P<0.05) increased BALF combined NO metabolites (84.8+/-2.2 microM 100 microl(-1)), compared with medium-inoculated (56.0+/-5.8) or naive animals (45.7+/-2.0). Treating the PI3-infected guinea-pigs with dexamethasone or rolipram significantly (P<0.001) reduced the raised NO metabolites by 34% and 37%, respectively. These results support a role for steroids and PDE4-inhibitors in the management of inflammation and airways hyperreactivity arising from viral infection of the airways.
将豚鼠接种3型副流感病毒(PI3)(5.2×10⁷)或培养基(每侧鼻孔125微升)。在接种前24小时和0.5小时以及此后4天,腹腔注射PDE4抑制剂咯利普兰(1毫克/千克)、皮质类固醇地塞米松(20毫克/千克)或赋形剂。通过全身体积描记法在清醒豚鼠中记录呼吸功能,以特异性气道传导率(sGaw)表示,接种培养基或PI3后4天内呼吸功能未受影响。接种前24小时吸入组胺(仅经鼻,1毫摩尔,20秒)无反应,但接种PI3后4天,出现显著(P<0.001)支气管收缩,表明气道高反应性(AHR)。地塞米松或咯利普兰治疗可抑制AHR。接种PI3或培养基4天后,对动物进行支气管肺泡灌洗(BAL),以进行总细胞和分类细胞(巨噬细胞、嗜酸性粒细胞和中性粒细胞)计数,并测定一氧化氮(NO)的亚硝酸盐和硝酸盐含量。与接种培养基的动物相比,接种PI3后4天收集的BAL液中巨噬细胞、嗜酸性粒细胞和中性粒细胞显著增加。地塞米松或咯利普兰显著(P<0.05)减少了PI3诱导的气道巨噬细胞(分别减少40%和47%)、嗜酸性粒细胞(79%和84%)和中性粒细胞(58%和61%)的流入。与接种培养基的动物(56.0±5.8)或未感染动物(45.7±2.0)相比,接种PI3显著(P<0.05)增加了BALF中NO代谢产物的总量(84.8±2.2微摩尔/100微升)。用地塞米松或咯利普兰治疗PI3感染的豚鼠,可使升高的NO代谢产物分别显著(P<0.001)降低34%和37%。这些结果支持类固醇和PDE4抑制剂在治疗气道病毒感染引起的炎症和气道高反应性方面的作用。